1. Home
  2. MXF vs ENLV Comparison

MXF vs ENLV Comparison

Compare MXF & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mexico Fund Inc. (The)

MXF

Mexico Fund Inc. (The)

HOLD

Current Price

$21.30

Market Cap

297.5M

Sector

Finance

ML Signal

HOLD

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$1.10

Market Cap

249.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MXF
ENLV
Founded
1981
2005
Country
Mexico
Israel
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
297.5M
249.3M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
MXF
ENLV
Price
$21.30
$1.10
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$13.00
AVG Volume (30 Days)
27.4K
485.5K
Earning Date
01-01-0001
03-30-2026
Dividend Yield
4.70%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.77
$0.66
52 Week High
$19.49
$2.10

Technical Indicators

Market Signals
Indicator
MXF
ENLV
Relative Strength Index (RSI) 68.12 67.64
Support Level $19.76 $0.92
Resistance Level $21.78 $1.03
Average True Range (ATR) 0.47 0.07
MACD 0.05 0.03
Stochastic Oscillator 74.75 98.55

Price Performance

Historical Comparison
MXF
ENLV

About MXF Mexico Fund Inc. (The)

Mexico Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation. The fund seeks to achieve its objective through investment in securities, primary in equity, listed on the Mexican Stock Exchange. The company's portfolio of investments consists of investments in different sectors such as auto parts, airports, building materials, chemical products, consumer products, energy, food, and other sectors. The fund provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Share on Social Networks: